Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is an aggressive human cancer with increasing incidence worldwide. Multiple efforts have been made to explore pharmaceutical therapies to treat HCC, such as targeted tyrosine kinase inhibitors, immune based therapies and combination of chemotherapy. However, limitation...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Buch |
| Veröffentlicht: |
Elsevier,
2022-02-01T00:00:00Z.
|
| Schlagworte: | |
| Online-Zugang: | Connect to this object online. |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|